Latest On Tricida, Inc (TCDA):
About Tricida, Inc (TCDA):
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
General
- Name Tricida, Inc
- Symbol TCDA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 64
- Last Split Factor1:3
- Last Split Date2018-06-15
- Fiscal Year EndDecember
- IPO Date2018-06-28
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.tricida.com
Valuation
- Price/Book (Most Recent Quarter) 2.33
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$3.81
- Next Year EPS Estimate -$3.38
- Next Quarter EPS Estimate -$1.02
- Return on Assets -41%
- Return on Equity -142%
- Earnings Per Share -$3.01
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 253.73 million
- EBITDA -133151000
- Analyst Target Price $15.33
- Book Value Per Share $2.17
Share Statistics
- Shares Outstanding 50.18 million
- Shares Float 29.93 million
- % Held by Insiders 274%
- % Held by Institutions 91.62%
- Shares Short 4.4 million
- Shares Short Prior Month 5.06 million
- Short Ratio 4.29
- Short % of Float 15%
- Short % of Shares Outstanding 9%
Technicals
- Beta 1.36
- 52 Week High $32.99
- 52 Week Low $4.1
- 50 Day Moving Average 6.15
- 200 Day Moving Average 7.72
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Tricida, Inc (TCDA) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Tricida, Inc (TCDA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-25 | $N/A | -$1.09 | -$1.12 | 2.96% |
2020-09-30 | 2020-11-09 | $N/A | -$1.55 | -$1.21 | -27.61% |
2020-06-30 | 2020-08-05 | $N/A | -$1.16 | -$1.46 | 20.55% |
2020-03-31 | 2020-05-07 | $N/A | -$1.49 | -$1.40 | -6.18% |
2019-12-31 | 2020-02-27 | $N/A | -$1.17 | -$1.21 | 3.27% |
2019-09-30 | 2019-11-14 | $N/A | -$0.89 | -$0.92 | 3.19% |
2019-06-30 | 2019-08-08 | $N/A | -$0.75 | -$0.86 | 12.95% |
2019-03-31 | 2019-05-08 | $N/A | -$0.90 | -$0.80 | -13.21% |
2018-12-31 | 2019-03-28 | $N/A | -$0.66 | -$0.88 | 25.31% |
2018-09-30 | 2018-11-08 | $N/A | -$0.71 | -$0.86 | 17.84% |
2018-06-30 | 2018-08-08 | $N/A | -$0.89 | -$1.05 | 15.62% |
Tricida, Inc (TCDA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
---|---|---|---|---|---|
Research Development | -27.28 million | N/A | N/A | N/A | 40.65 million |
Income Before Tax | -54.79 million | N/A | N/A | N/A | -58.26 million |
Selling General Administrative | -21.77 million | N/A | N/A | N/A | 17.46 million |
Gross Profit | N/A | N/A | N/A | N/A | N/A |
Ebit | -48.43 million | N/A | N/A | N/A | -58.12 million |
Operating Income | -49.05 million | N/A | N/A | N/A | -58.12 million |
Income Tax Expense | N/A | 36000 | -86000 | N/A | -92000 |
Total Revenue | N/A | N/A | N/A | N/A | N/A |
Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
Total Other Income Expense Net | N/A | N/A | N/A | N/A | -147000 |
Net Income From Continuing Operations | -54.84 million | N/A | N/A | N/A | -58.17 million |
Net Income Applicable to Common Shares | -54.84 million | -77.67 million | -58.17 million | -74.11 million | -58.17 million |
Cash Flow:
Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
---|---|---|---|---|---|
Investments | N/A | N/A | N/A | N/A | N/A |
Change to Liabilities | -4 million | -5.01 million | N/A | N/A | N/A |
Total Cash Flow from Investing Activities | 47.79 million | -100.4 million | N/A | N/A | N/A |
Net Borrowings | -29000 | 208.24 million | N/A | N/A | N/A |
Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | N/A |
Change to Operating Activities | 10.33 million | -23.74 million | N/A | N/A | N/A |
Change in Cash | N/A | N/A | N/A | N/A | N/A |
Total Cash from Operating Activities | -60.18 million | -77.6 million | N/A | N/A | N/A |
Depreciation | N/A | N/A | N/A | N/A | N/A |
Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
Change to Inventory | N/A | N/A | N/A | N/A | N/A |
Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
Change to Net Income | 7.8 million | 7.42 million | N/A | N/A | N/A |
Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
---|---|---|---|---|---|
Total Liabailities | 242.81 million | N/A | N/A | N/A | 107.94 million |
Total Stockholder Equity | 108.87 million | N/A | N/A | N/A | 263.88 million |
Other Current Liabilities | 2.08 million | N/A | N/A | N/A | N/A |
Total Assets | 351.69 million | N/A | N/A | N/A | 371.83 million |
Common Stock | 50000 | 50000 | 50000 | 50000 | 50000 |
Other Current Assets | 18.29 million | N/A | N/A | N/A | N/A |
Retained Earnings | -633.8 million | -578.96 million | -501.29 million | -443.12 million | -369.01 million |
Other Liabilities | N/A | 278000 | 327000 | 1.85 million | 1.02 million |
Other Assets | N/A | N/A | N/A | N/A | N/A |
Cash | 160.61 million | N/A | N/A | N/A | 18.57 million |
Total Current Liabilities | 34.26 million | 46.58 million | N/A | N/A | 39.76 million |
Other Stockholder Equity | 64000 | 432000 | 863000 | -39000 | 193000 |
Property, Plant & Equipment | 1.11 million | 15.99 million | 10.17 million | 10.48 million | 12.1 million |
Total Current Assets | 314.02 million | 326.06 million | N/A | N/A | 312.74 million |
Long Term Investments | N/A | N/A | N/A | N/A | 46.98 million |
Net Tangible Assets | 108.87 million | 160.77 million | 230.98 million | 198.46 million | 263.88 million |
Short Term Investments | 171.67 million | N/A | N/A | N/A | 289.42 million |
Long Term Debt | 195.31 million | N/A | N/A | N/A | 58.37 million |
Inventory | N/A | N/A | N/A | N/A | N/A |
Accounts Payable | 32.38 million | 1.79 million | N/A | N/A | 5.91 million |
Tricida, Inc (TCDA) Chart:
Tricida, Inc (TCDA) News:
Below you will find a list of latest news for Tricida, Inc (TCDA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Tricida, Inc (TCDA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest TCDA Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 2 | $8.19 |
Jun 13, 2022 7:59 PM EST | 56 | $8.19 |
Jun 13, 2022 7:59 PM EST | 14 | $8.19 |
Jun 13, 2022 7:59 PM EST | 1 | $8.19 |
Jun 13, 2022 7:59 PM EST | 444 | $8.21 |
Tricida, Inc (TCDA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000104/0001595585-20-000104-index.htm |
2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595585/000008025520001339/0000080255-20-001339-index.htm |
2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595585/000083423720008045/0000834237-20-008045-index.htm |
2020-10-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595585/000083423720010345/0000834237-20-010345-index.htm |
2020-01-27 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1595585/000090221920000133/0000902219-20-000133-index.htm |
2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000094787119000271/0000947871-19-000271-index.htm |
2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000094787119000272/0000947871-19-000272-index.htm |
2019-04-09 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1595585/000094787119000277/0000947871-19-000277-index.htm |
2019-12-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1595585/000094787119000958/0000947871-19-000958-index.htm |
2019-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000094787119000959/0000947871-19-000959-index.htm |
2019-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000094787119000960/0000947871-19-000960-index.htm |
2020-06-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1595585/000110465920069481/0001104659-20-069481-index.htm |
2020-04-17 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1595585/000114036120009189/0001140361-20-009189-index.htm |
2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1595585/000114036120010122/0001140361-20-010122-index.htm |
2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1595585/000114036120010125/0001140361-20-010125-index.htm |
2019-04-18 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1595585/000114420419020252/0001144204-19-020252-index.htm |
2019-04-18 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1595585/000114420419020257/0001144204-19-020257-index.htm |
2019-04-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1595585/000119312519103856/0001193125-19-103856-index.htm |
2019-11-27 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1595585/000119312519302571/0001193125-19-302571-index.htm |
2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000078/0001595585-19-000078-index.htm |
2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000083/0001595585-19-000083-index.htm |
2019-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000087/0001595585-19-000087-index.htm |
2019-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000089/0001595585-19-000089-index.htm |
2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000102/0001595585-19-000102-index.htm |
2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000103/0001595585-19-000103-index.htm |
2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000104/0001595585-19-000104-index.htm |
2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000105/0001595585-19-000105-index.htm |
2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000106/0001595585-19-000106-index.htm |
2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000107/0001595585-19-000107-index.htm |
2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000112/0001595585-19-000112-index.htm |
2019-07-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000122/0001595585-19-000122-index.htm |
2019-07-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000123/0001595585-19-000123-index.htm |
2019-07-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000124/0001595585-19-000124-index.htm |
2019-07-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000125/0001595585-19-000125-index.htm |
2019-07-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000126/0001595585-19-000126-index.htm |
2019-07-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000127/0001595585-19-000127-index.htm |
2019-07-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000129/0001595585-19-000129-index.htm |
2019-07-08 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000131/0001595585-19-000131-index.htm |
2019-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000136/0001595585-19-000136-index.htm |
2019-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000137/0001595585-19-000137-index.htm |
2019-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000138/0001595585-19-000138-index.htm |
2019-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000139/0001595585-19-000139-index.htm |
2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000142/0001595585-19-000142-index.htm |
2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000143/0001595585-19-000143-index.htm |
2019-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000146/0001595585-19-000146-index.htm |
2019-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000147/0001595585-19-000147-index.htm |
2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000149/0001595585-19-000149-index.htm |
2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000151/0001595585-19-000151-index.htm |
2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000161/0001595585-19-000161-index.htm |
2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000166/0001595585-19-000166-index.htm |
2019-08-09 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000167/0001595585-19-000167-index.htm |
2019-08-09 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000168/0001595585-19-000168-index.htm |
2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000170/0001595585-19-000170-index.htm |
2019-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000175/0001595585-19-000175-index.htm |
2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000177/0001595585-19-000177-index.htm |
2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000178/0001595585-19-000178-index.htm |
2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000179/0001595585-19-000179-index.htm |
2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000180/0001595585-19-000180-index.htm |
2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000181/0001595585-19-000181-index.htm |
2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000182/0001595585-19-000182-index.htm |
2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000183/0001595585-19-000183-index.htm |
2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000184/0001595585-19-000184-index.htm |
2019-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000186/0001595585-19-000186-index.htm |
2019-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000188/0001595585-19-000188-index.htm |
2019-08-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000191/0001595585-19-000191-index.htm |
2019-08-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000192/0001595585-19-000192-index.htm |
2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000204/0001595585-19-000204-index.htm |
2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000206/0001595585-19-000206-index.htm |
2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000209/0001595585-19-000209-index.htm |
2019-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000211/0001595585-19-000211-index.htm |
2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000213/0001595585-19-000213-index.htm |
2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000215/0001595585-19-000215-index.htm |
2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000216/0001595585-19-000216-index.htm |
2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000218/0001595585-19-000218-index.htm |
2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000221/0001595585-19-000221-index.htm |
2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000223/0001595585-19-000223-index.htm |
2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000225/0001595585-19-000225-index.htm |
2019-10-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000227/0001595585-19-000227-index.htm |
2019-10-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000233/0001595585-19-000233-index.htm |
2019-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000236/0001595585-19-000236-index.htm |
2019-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000238/0001595585-19-000238-index.htm |
2019-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000239/0001595585-19-000239-index.htm |
2019-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000240/0001595585-19-000240-index.htm |
2019-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000241/0001595585-19-000241-index.htm |
2019-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000242/0001595585-19-000242-index.htm |
2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000243/0001595585-19-000243-index.htm |
2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000244/0001595585-19-000244-index.htm |
2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000245/0001595585-19-000245-index.htm |
2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000246/0001595585-19-000246-index.htm |
2019-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000247/0001595585-19-000247-index.htm |
2019-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000248/0001595585-19-000248-index.htm |
2019-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000249/0001595585-19-000249-index.htm |
2019-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000250/0001595585-19-000250-index.htm |
2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000251/0001595585-19-000251-index.htm |
2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000252/0001595585-19-000252-index.htm |
2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000253/0001595585-19-000253-index.htm |
2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000257/0001595585-19-000257-index.htm |
2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000259/0001595585-19-000259-index.htm |
2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000260/0001595585-19-000260-index.htm |
2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000261/0001595585-19-000261-index.htm |
2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000262/0001595585-19-000262-index.htm |
2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000263/0001595585-19-000263-index.htm |
2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000264/0001595585-19-000264-index.htm |
2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000265/0001595585-19-000265-index.htm |
2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000266/0001595585-19-000266-index.htm |
2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000267/0001595585-19-000267-index.htm |
2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000268/0001595585-19-000268-index.htm |
2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000269/0001595585-19-000269-index.htm |
2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000271/0001595585-19-000271-index.htm |
2019-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000272/0001595585-19-000272-index.htm |
2019-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000273/0001595585-19-000273-index.htm |
2019-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000276/0001595585-19-000276-index.htm |
2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000277/0001595585-19-000277-index.htm |
2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000278/0001595585-19-000278-index.htm |
2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000280/0001595585-19-000280-index.htm |
2019-12-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000282/0001595585-19-000282-index.htm |
2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000001/0001595585-20-000001-index.htm |
2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000002/0001595585-20-000002-index.htm |
2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000003/0001595585-20-000003-index.htm |
2020-01-08 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000004/0001595585-20-000004-index.htm |
2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000007/0001595585-20-000007-index.htm |
2020-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000008/0001595585-20-000008-index.htm |
2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000009/0001595585-20-000009-index.htm |
2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000010/0001595585-20-000010-index.htm |
2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000011/0001595585-20-000011-index.htm |
2020-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000012/0001595585-20-000012-index.htm |
2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000013/0001595585-20-000013-index.htm |
2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000014/0001595585-20-000014-index.htm |
2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000015/0001595585-20-000015-index.htm |
2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000016/0001595585-20-000016-index.htm |
2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000017/0001595585-20-000017-index.htm |
2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000018/0001595585-20-000018-index.htm |
2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000019/0001595585-20-000019-index.htm |
2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000024/0001595585-20-000024-index.htm |
2020-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000027/0001595585-20-000027-index.htm |
2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000032/0001595585-20-000032-index.htm |
2020-03-02 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000034/0001595585-20-000034-index.htm |
2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000035/0001595585-20-000035-index.htm |
2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000036/0001595585-20-000036-index.htm |
2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000037/0001595585-20-000037-index.htm |
2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000038/0001595585-20-000038-index.htm |
2020-03-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000041/0001595585-20-000041-index.htm |
2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000043/0001595585-20-000043-index.htm |
2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000046/0001595585-20-000046-index.htm |
2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000047/0001595585-20-000047-index.htm |
2020-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000049/0001595585-20-000049-index.htm |
2020-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000052/0001595585-20-000052-index.htm |
2020-04-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000053/0001595585-20-000053-index.htm |
2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000055/0001595585-20-000055-index.htm |
2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000057/0001595585-20-000057-index.htm |
2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000062/0001595585-20-000062-index.htm |
2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000064/0001595585-20-000064-index.htm |
2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000066/0001595585-20-000066-index.htm |
2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000068/0001595585-20-000068-index.htm |
2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000069/0001595585-20-000069-index.htm |
2020-05-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000073/0001595585-20-000073-index.htm |
2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000075/0001595585-20-000075-index.htm |
2020-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000077/0001595585-20-000077-index.htm |
2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000080/0001595585-20-000080-index.htm |
2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000082/0001595585-20-000082-index.htm |
2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000084/0001595585-20-000084-index.htm |
2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000085/0001595585-20-000085-index.htm |
2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000086/0001595585-20-000086-index.htm |
2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000087/0001595585-20-000087-index.htm |
2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000088/0001595585-20-000088-index.htm |
2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000094/0001595585-20-000094-index.htm |
2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000096/0001595585-20-000096-index.htm |
2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000099/0001595585-20-000099-index.htm |
2020-07-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000101/0001595585-20-000101-index.htm |
2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000102/0001595585-20-000102-index.htm |
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000104/0001595585-20-000104-index.htm |
2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000106/0001595585-20-000106-index.htm |
2020-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000108/0001595585-20-000108-index.htm |
2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000112/0001595585-20-000112-index.htm |
2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000116/0001595585-20-000116-index.htm |
2020-08-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000118/0001595585-20-000118-index.htm |
2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000120/0001595585-20-000120-index.htm |
2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000121/0001595585-20-000121-index.htm |
2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000122/0001595585-20-000122-index.htm |
2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000123/0001595585-20-000123-index.htm |
2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000124/0001595585-20-000124-index.htm |
2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000125/0001595585-20-000125-index.htm |
2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000126/0001595585-20-000126-index.htm |
2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000129/0001595585-20-000129-index.htm |
2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000162828020009469/0001628280-20-009469-index.htm |
2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000174498119000002/0001744981-19-000002-index.htm |
2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1595585/000174498119000003/0001744981-19-000003-index.htm |
Tricida, Inc (TCDA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tricida, Inc (TCDA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 274%Institutional Ownership: 9162%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2019-07-03 | Claire Lockey | Chief Dev. Officer and Sr. VP | Sell | 40,401.00 | 37.10 | 1,498,877.10 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000124/0001595585-19-000124-index.htm |
2019-08-01 | Claire Lockey | Chief Dev. Officer and Sr. VP | Sell | 10,000.00 | 32.02 | 320,200.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000149/0001595585-19-000149-index.htm |
2019-09-03 | Claire Lockey | Chief Dev. Officer and Sr. VP | Sell | 602.00 | 34.43 | 20,726.86 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000209/0001595585-19-000209-index.htm |
2019-10-01 | Claire Lockey | Chief Dev. Officer and Sr. VP | Sell | 1,650.00 | 31.35 | 51,727.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000225/0001595585-19-000225-index.htm |
2019-11-01 | Claire Lockey | Chief Dev. Officer and Sr. VP | Sell | 448.00 | 37.25 | 16,688.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000244/0001595585-19-000244-index.htm |
2019-11-01 | Claire Lockey | Chief Dev. Officer and Sr. VP | Sell | 6,400.00 | 38.74 | 247,936.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000244/0001595585-19-000244-index.htm |
2019-07-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 15,407.00 | 37.04 | 570,675.28 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000125/0001595585-19-000125-index.htm |
2019-07-29 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 5,000.00 | 31.19 | 155,950.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000147/0001595585-19-000147-index.htm |
2019-08-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 1,500.00 | 33.67 | 50,505.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000192/0001595585-19-000192-index.htm |
2019-08-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 3,500.00 | 33.70 | 117,950.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000192/0001595585-19-000192-index.htm |
2019-09-25 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 271.00 | 32.92 | 8,921.32 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000213/0001595585-19-000213-index.htm |
2019-10-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 78.00 | 37.73 | 2,942.94 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000242/0001595585-19-000242-index.htm |
2019-10-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 112.00 | 37.78 | 4,231.36 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000242/0001595585-19-000242-index.htm |
2019-11-26 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 739.00 | 39.59 | 29,257.01 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000268/0001595585-19-000268-index.htm |
2019-11-26 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 1,884.00 | 39.60 | 74,606.40 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000268/0001595585-19-000268-index.htm |
2019-11-26 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 1,507.00 | 39.61 | 59,692.27 | 0.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000268/0001595585-19-000268-index.htm |
2019-08-01 | Claire Lockey | Chief Dev. Officer and Sr. VP | Buy | 10,000.00 | 0.80 | 8,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000149/0001595585-19-000149-index.htm |
2019-09-03 | Claire Lockey | Chief Dev. Officer and Sr. VP | Buy | 10,000.00 | 0.80 | 8,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000209/0001595585-19-000209-index.htm |
2019-10-01 | Claire Lockey | Chief Dev. Officer and Sr. VP | Buy | 10,000.00 | 0.80 | 8,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000225/0001595585-19-000225-index.htm |
2019-11-01 | Claire Lockey | Chief Dev. Officer and Sr. VP | Buy | 10,100.00 | 0.72 | 7,272.00 | 10,100.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000244/0001595585-19-000244-index.htm |
2019-07-05 | SANDRA I COUFAL | Director | Sell | 1,620.00 | 36.22 | 58,676.40 | 10,105.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000136/0001595585-19-000136-index.htm |
2019-08-28 | GERRIT KLAERNER | President and CEO | Sell | 2,000.00 | 33.71 | 67,420.00 | 102,273.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000191/0001595585-19-000191-index.htm |
2019-07-29 | GERRIT KLAERNER | President and CEO | Sell | 2,000.00 | 31.17 | 62,340.00 | 104,273.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000146/0001595585-19-000146-index.htm |
2020-05-05 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 798.00 | 1.68 | 1,340.64 | 1,053.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000064/0001595585-20-000064-index.htm |
2019-07-08 | GERRIT KLAERNER | President and CEO | Sell | 1,282.00 | 34.64 | 44,408.48 | 106,273.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000137/0001595585-19-000137-index.htm |
2019-07-05 | GERRIT KLAERNER | President and CEO | Sell | 1,615.00 | 36.28 | 58,592.20 | 107,555.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000137/0001595585-19-000137-index.htm |
2020-05-08 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 830.00 | 1.68 | 1,394.40 | 1,085.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000068/0001595585-20-000068-index.htm |
2019-07-03 | GERRIT KLAERNER | President and CEO | Sell | 3,503.00 | 37.08 | 129,891.24 | 109,170.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000129/0001595585-19-000129-index.htm |
2019-04-03 | David P Bonita | Director | Buy | 225,000.00 | 36.00 | 8,100,000.00 | 11,114,280.00 | https://www.sec.gov/Archives/edgar/data/1595585/000094787119000272/0000947871-19-000272-index.htm |
2019-04-03 | ORBIMED ADVISORS LLC | Director | Buy | 225,000.00 | 36.00 | 8,100,000.00 | 11,114,280.00 | https://www.sec.gov/Archives/edgar/data/1595585/000094787119000271/0000947871-19-000271-index.htm |
2020-06-11 | David Hirsch | Director | Buy | 5,670.00 | 11,181.00 | https://www.sec.gov/Archives/edgar/data/1595585/000162828020009469/0001628280-20-009469-index.htm | ||
2020-06-11 | David P Bonita | Director | Buy | 5,670.00 | 11,181.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000088/0001595585-20-000088-index.htm | ||
2019-10-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 1,162.00 | 37.22 | 43,249.64 | 112.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000242/0001595585-19-000242-index.htm |
2019-07-03 | SANDRA I COUFAL | Director | Sell | 4,000.00 | 37.03 | 148,120.00 | 11,725.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000123/0001595585-19-000123-index.htm |
2019-10-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 257.00 | 37.81 | 9,717.17 | 1,274.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000242/0001595585-19-000242-index.htm |
2019-11-26 | Robert J Alpern | Director | Sell | 1,000.00 | 39.59 | 39,590.00 | 137,390.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000267/0001595585-19-000267-index.htm |
2019-11-20 | Robert J Alpern | Director | Sell | 2,439.00 | 40.65 | 99,145.35 | 138,390.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000263/0001595585-19-000263-index.htm |
2019-11-12 | Robert J Alpern | Director | Sell | 1,159.00 | 39.92 | 46,267.28 | 140,829.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000261/0001595585-19-000261-index.htm |
2019-11-07 | Robert J Alpern | Director | Sell | 3,953.00 | 39.93 | 157,843.29 | 141,988.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000252/0001595585-19-000252-index.htm |
2020-06-11 | Robert J Alpern | Director | Buy | 5,670.00 | 143,060.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000084/0001595585-20-000084-index.htm | ||
2019-11-06 | Robert J Alpern | Director | Sell | 227.00 | 39.75 | 9,023.25 | 145,941.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000250/0001595585-19-000250-index.htm |
2019-11-05 | Robert J Alpern | Director | Sell | 1,605.00 | 39.89 | 64,023.45 | 146,168.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000250/0001595585-19-000250-index.htm |
2019-11-04 | Robert J Alpern | Director | Sell | 2,617.00 | 39.84 | 104,261.28 | 147,773.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000247/0001595585-19-000247-index.htm |
2019-07-03 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 3,000.00 | 36.91 | 110,730.00 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000126/0001595585-19-000126-index.htm |
2019-07-05 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 1,615.00 | 36.28 | 58,592.20 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000138/0001595585-19-000138-index.htm |
2019-07-08 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 3,085.00 | 34.67 | 106,956.95 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000138/0001595585-19-000138-index.htm |
2019-08-02 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 2,000.00 | 30.92 | 61,840.00 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000151/0001595585-19-000151-index.htm |
2019-09-04 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 500.00 | 33.57 | 16,785.00 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000211/0001595585-19-000211-index.htm |
2019-09-26 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 223.00 | 32.46 | 7,238.58 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000216/0001595585-19-000216-index.htm |
2019-10-03 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 2,000.00 | 31.16 | 62,320.00 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000227/0001595585-19-000227-index.htm |
2019-10-25 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 50.00 | 36.29 | 1,814.50 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000238/0001595585-19-000238-index.htm |
2019-10-25 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 4,950.00 | 36.37 | 180,031.50 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000238/0001595585-19-000238-index.htm |
2019-11-04 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 651.00 | 40.00 | 26,040.00 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000248/0001595585-19-000248-index.htm |
2019-11-05 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 991.00 | 40.02 | 39,659.82 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000249/0001595585-19-000249-index.htm |
2019-11-06 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 48.00 | 39.97 | 1,918.56 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000249/0001595585-19-000249-index.htm |
2019-11-07 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 2,910.00 | 39.97 | 116,312.70 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000253/0001595585-19-000253-index.htm |
2019-11-12 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 836.00 | 39.97 | 33,414.92 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000260/0001595585-19-000260-index.htm |
2019-11-20 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 814.00 | 40.81 | 33,219.34 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000264/0001595585-19-000264-index.htm |
2019-12-23 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 50.00 | 38.90 | 1,945.00 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000280/0001595585-19-000280-index.htm |
2019-12-23 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 2,950.00 | 38.91 | 114,784.50 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000280/0001595585-19-000280-index.htm |
2020-02-05 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 500.00 | 38.91 | 19,455.00 | 14,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000012/0001595585-20-000012-index.htm |
2019-11-06 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 48.00 | 1.68 | 80.64 | 14,854.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000249/0001595585-19-000249-index.htm |
2019-10-25 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 50.00 | 0.72 | 36.00 | 14,856.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000238/0001595585-19-000238-index.htm |
2019-12-23 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 50.00 | 0.72 | 36.00 | 14,856.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000280/0001595585-19-000280-index.htm |
2019-12-20 | EDWARD J HEJLEK | SVP, General Counsel & Secy. | Sell | 15,000.00 | 38.17 | 572,550.00 | 14,882.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000278/0001595585-19-000278-index.htm |
2019-08-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 1,500.00 | 1.68 | 2,520.00 | 1,500.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000192/0001595585-19-000192-index.htm |
2019-07-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 5,950.00 | 1.68 | 9,996.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000125/0001595585-19-000125-index.htm |
2019-09-26 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 762.00 | 32.07 | 24,437.34 | 15,029.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000216/0001595585-19-000216-index.htm |
2019-10-25 | Robert J Alpern | Director | Sell | 1,000.00 | 36.29 | 36,290.00 | 150,390.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000239/0001595585-19-000239-index.htm |
2020-04-28 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 1,250.00 | 1.68 | 2,100.00 | 1,505.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000055/0001595585-20-000055-index.htm |
2019-11-26 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 1,507.00 | 2.39 | 3,601.73 | 1,507.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000268/0001595585-19-000268-index.htm |
2019-10-25 | Robert J Alpern | Director | Sell | 346.00 | 37.24 | 12,885.04 | 151,390.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000239/0001595585-19-000239-index.htm |
2019-10-25 | Robert J Alpern | Director | Sell | 9,654.00 | 36.52 | 352,564.08 | 151,736.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000239/0001595585-19-000239-index.htm |
2020-02-05 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 500.00 | 1.68 | 840.00 | 15,306.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000012/0001595585-20-000012-index.htm |
2019-09-04 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 1,500.00 | 33.16 | 49,740.00 | 15,306.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000211/0001595585-19-000211-index.htm |
2019-10-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 3,243.00 | 37.21 | 120,672.03 | 1,531.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000242/0001595585-19-000242-index.htm |
2019-11-04 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 2,000.00 | 39.56 | 79,120.00 | 15,457.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000248/0001595585-19-000248-index.htm |
2019-08-12 | Geoffrey M. Parker | Chief Fin. Officer and Sr. VP | Buy | 15,476.00 | 31.64 | 489,660.64 | 15,476.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000170/0001595585-19-000170-index.htm |
2019-11-20 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 814.00 | 1.68 | 1,367.52 | 15,620.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000264/0001595585-19-000264-index.htm |
2019-11-12 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 836.00 | 1.68 | 1,404.48 | 15,642.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000260/0001595585-19-000260-index.htm |
2019-09-26 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Sell | 1,015.00 | 30.71 | 31,170.65 | 15,791.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000216/0001595585-19-000216-index.htm |
2019-11-05 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 991.00 | 1.68 | 1,664.88 | 15,797.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000249/0001595585-19-000249-index.htm |
2019-09-26 | Robert J Alpern | Director | Sell | 21.00 | 32.63 | 685.23 | 161,390.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000215/0001595585-19-000215-index.htm |
2019-09-26 | Robert J Alpern | Director | Sell | 461.00 | 32.15 | 14,821.15 | 161,411.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000215/0001595585-19-000215-index.htm |
2019-09-26 | Robert J Alpern | Director | Sell | 518.00 | 30.76 | 15,933.68 | 161,872.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000215/0001595585-19-000215-index.htm |
2019-08-26 | Robert J Alpern | Director | Sell | 1,000.00 | 33.19 | 33,190.00 | 162,390.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000186/0001595585-19-000186-index.htm |
2019-07-25 | Robert J Alpern | Director | Sell | 1,000.00 | 31.60 | 31,600.00 | 163,390.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000142/0001595585-19-000142-index.htm |
2019-07-05 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 1,615.00 | 0.72 | 1,162.80 | 16,421.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000138/0001595585-19-000138-index.htm |
2019-07-03 | Robert J Alpern | Director | Sell | 3,000.00 | 37.05 | 111,150.00 | 164,390.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000122/0001595585-19-000122-index.htm |
2019-10-01 | Claire Lockey | Chief Dev. Officer and Sr. VP | Sell | 8,350.00 | 30.64 | 255,844.00 | 1,650.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000225/0001595585-19-000225-index.htm |
2019-05-31 | Robert J Alpern | Director | Buy | 1,879.00 | 167,390.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000102/0001595585-19-000102-index.htm | ||
2019-08-02 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 2,000.00 | 0.72 | 1,440.00 | 16,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000151/0001595585-19-000151-index.htm |
2019-09-04 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 2,000.00 | 0.72 | 1,440.00 | 16,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000211/0001595585-19-000211-index.htm |
2019-09-26 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 2,000.00 | 0.72 | 1,440.00 | 16,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000216/0001595585-19-000216-index.htm |
2019-10-03 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 2,000.00 | 1.68 | 3,360.00 | 16,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000227/0001595585-19-000227-index.htm |
2020-05-08 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 1,437.00 | 2.39 | 3,434.43 | 1,692.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000068/0001595585-20-000068-index.htm |
2019-11-04 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 2,651.00 | 1.68 | 4,453.68 | 17,457.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000248/0001595585-19-000248-index.htm |
2019-11-07 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 2,910.00 | 1.68 | 4,888.80 | 17,716.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000253/0001595585-19-000253-index.htm |
2019-12-23 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 2,950.00 | 1.68 | 4,956.00 | 17,756.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000280/0001595585-19-000280-index.htm |
2019-07-03 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 3,000.00 | 0.72 | 2,160.00 | 17,806.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000126/0001595585-19-000126-index.htm |
2019-07-08 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 3,085.00 | 0.72 | 2,221.20 | 17,891.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000138/0001595585-19-000138-index.htm |
2019-08-12 | Geoffrey M. Parker | Chief Fin. Officer and Sr. VP | Buy | 2,577.00 | 32.56 | 83,907.12 | 18,053.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000170/0001595585-19-000170-index.htm |
2019-11-26 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 1,884.00 | 1.68 | 3,165.12 | 1,884.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000268/0001595585-19-000268-index.htm |
2019-12-26 | EDWARD J HEJLEK | SVP, General Counsel & Secy. | Buy | 4,200.00 | 0.96 | 4,032.00 | 19,082.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000282/0001595585-19-000282-index.htm |
2020-01-02 | EDWARD J HEJLEK | SVP, General Counsel & Secy. | Sell | 9,948.00 | 37.01 | 368,175.48 | 19,153.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000002/0001595585-20-000002-index.htm |
2020-01-02 | EDWARD J HEJLEK | SVP, General Counsel & Secy. | Sell | 52.00 | 38.00 | 1,976.00 | 19,153.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000002/0001595585-20-000002-index.htm |
2020-02-03 | EDWARD J HEJLEK | SVP, General Counsel & Secy. | Sell | 2,131.00 | 35.63 | 75,927.53 | 19,153.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000010/0001595585-20-000010-index.htm |
2020-02-03 | EDWARD J HEJLEK | SVP, General Counsel & Secy. | Sell | 7,869.00 | 36.63 | 288,241.47 | 19,153.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000010/0001595585-20-000010-index.htm |
2020-03-02 | EDWARD J HEJLEK | EVP, General Counsel & Secy. | Sell | 9,800.00 | 31.65 | 310,170.00 | 19,153.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000036/0001595585-20-000036-index.htm |
2020-03-02 | EDWARD J HEJLEK | EVP, General Counsel & Secy. | Sell | 200.00 | 32.23 | 6,446.00 | 19,153.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000036/0001595585-20-000036-index.htm |
2020-01-02 | EDWARD J HEJLEK | SVP, General Counsel & Secy. | Buy | 52.00 | 0.96 | 49.92 | 19,205.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000002/0001595585-20-000002-index.htm |
2020-03-02 | EDWARD J HEJLEK | EVP, General Counsel & Secy. | Buy | 200.00 | 0.96 | 192.00 | 19,353.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000036/0001595585-20-000036-index.htm |
2020-09-10 | Wilhelm Stahl | EVP, Chief Tech Officer | Buy | 4,000.00 | 19,478.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000124/0001595585-20-000124-index.htm | ||
2019-10-25 | Wilhelm Stahl | Chief Tech Officer & Sr. VP | Buy | 4,950.00 | 1.68 | 8,316.00 | 19,756.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000238/0001595585-19-000238-index.htm |
2020-04-29 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 1,744.00 | 1.68 | 2,929.92 | 1,999.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000055/0001595585-20-000055-index.htm |
2020-02-03 | EDWARD J HEJLEK | SVP, General Counsel & Secy. | Buy | 2,131.00 | 0.96 | 2,045.76 | 21,284.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000010/0001595585-20-000010-index.htm |
2020-01-02 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 1,885.00 | 1.68 | 3,166.80 | 2,140.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000003/0001595585-20-000003-index.htm |
2019-12-10 | SANDRA I COUFAL | Director | Sell | 713.00 | 43.28 | 30,858.64 | 216,939.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000273/0001595585-19-000273-index.htm |
2019-11-20 | SANDRA I COUFAL | Director | Sell | 713.00 | 40.21 | 28,669.73 | 217,652.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000265/0001595585-19-000265-index.htm |
2019-11-01 | SANDRA I COUFAL | Director | Sell | 713.00 | 38.86 | 27,707.18 | 218,365.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000243/0001595585-19-000243-index.htm |
2019-05-31 | SANDRA I COUFAL | Director | Buy | 1,879.00 | 219,078.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000104/0001595585-19-000104-index.htm | ||
2020-06-11 | SANDRA I COUFAL | Director | Buy | 5,670.00 | 222,609.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000087/0001595585-20-000087-index.htm | ||
2019-11-26 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 2,355.00 | 0.80 | 1,884.00 | 2,355.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000268/0001595585-19-000268-index.htm |
2019-04-04 | Geoffrey M. Parker | Chief Fin. Officer and Sr. VP | Buy | 20,000.00 | 36.00 | 720,000.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000078/0001595585-19-000078-index.htm |
2020-07-15 | GERRIT KLAERNER | President and CEO | Sell | 4,000.00 | 26.33 | 105,320.00 | 25,323.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000108/0001595585-20-000108-index.htm |
2019-08-13 | Geoffrey M. Parker | Chief Fin. Officer and Sr. VP | Buy | 7,416.00 | 32.91 | 244,060.56 | 25,469.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000170/0001595585-19-000170-index.htm |
2020-01-02 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 1,885.00 | 36.84 | 69,443.40 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000003/0001595585-20-000003-index.htm |
2020-01-02 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 2,365.00 | 37.20 | 87,978.00 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000003/0001595585-20-000003-index.htm |
2020-02-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 210.00 | 35.58 | 7,471.80 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000011/0001595585-20-000011-index.htm |
2020-02-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 523.00 | 37.31 | 19,513.13 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000011/0001595585-20-000011-index.htm |
2020-02-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 400.00 | 37.51 | 15,004.00 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000011/0001595585-20-000011-index.htm |
2020-02-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 523.00 | 37.62 | 19,675.26 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000011/0001595585-20-000011-index.htm |
2020-03-02 | Dawn Parsell Otto | EVP, Clinical Development | Sell | 2,994.00 | 31.78 | 95,149.32 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000037/0001595585-20-000037-index.htm |
2020-03-02 | Dawn Parsell Otto | EVP, Clinical Development | Sell | 210.00 | 31.98 | 6,715.80 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000037/0001595585-20-000037-index.htm |
2020-04-28 | Dawn Parsell Otto | EVP, Clinical Development | Sell | 1,250.00 | 29.98 | 37,475.00 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000055/0001595585-20-000055-index.htm |
2020-04-29 | Dawn Parsell Otto | EVP, Clinical Development | Sell | 210.00 | 31.98 | 6,715.80 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000055/0001595585-20-000055-index.htm |
2020-05-05 | Dawn Parsell Otto | EVP, Clinical Development | Sell | 798.00 | 30.05 | 23,979.90 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000064/0001595585-20-000064-index.htm |
2020-05-05 | Dawn Parsell Otto | EVP, Clinical Development | Sell | 452.00 | 30.31 | 13,700.12 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000064/0001595585-20-000064-index.htm |
2020-05-08 | Dawn Parsell Otto | EVP, Clinical Development | Sell | 210.00 | 31.98 | 6,715.80 | 255.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000068/0001595585-20-000068-index.htm |
2020-01-02 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 2,365.00 | 1.68 | 3,973.20 | 2,620.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000003/0001595585-20-000003-index.htm |
2020-02-03 | EDWARD J HEJLEK | SVP, General Counsel & Secy. | Buy | 7,869.00 | 0.96 | 7,554.24 | 27,022.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000010/0001595585-20-000010-index.htm |
2019-09-25 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 3,229.00 | 32.40 | 104,619.60 | 271.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000213/0001595585-19-000213-index.htm |
2019-07-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 2,769.00 | 0.80 | 2,215.20 | 2,769.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000125/0001595585-19-000125-index.htm |
2019-11-22 | Brian M. Isern | 10% Share Holder | Sell | 132,834.00 | 41.17 | 5,468,775.78 | 2,773,350.00 | https://www.sec.gov/Archives/edgar/data/1595585/000174498119000003/0001744981-19-000003-index.htm |
2019-11-22 | SANDRA I COUFAL | Director | Sell | 132,834.00 | 41.17 | 5,468,775.78 | 2,773,350.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000266/0001595585-19-000266-index.htm |
2020-03-02 | EDWARD J HEJLEK | EVP, General Counsel & Secy. | Buy | 9,800.00 | 0.96 | 9,408.00 | 28,953.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000036/0001595585-20-000036-index.htm |
2019-11-22 | Brian M. Isern | 10% Share Holder | Sell | 48,030.00 | 40.53 | 1,946,655.90 | 2,906,184.00 | https://www.sec.gov/Archives/edgar/data/1595585/000174498119000003/0001744981-19-000003-index.htm |
2019-11-22 | SANDRA I COUFAL | Director | Sell | 48,030.00 | 40.53 | 1,946,655.90 | 2,906,184.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000266/0001595585-19-000266-index.htm |
2020-01-02 | EDWARD J HEJLEK | SVP, General Counsel & Secy. | Buy | 9,948.00 | 0.96 | 9,550.08 | 29,101.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000002/0001595585-20-000002-index.htm |
2020-06-15 | GERRIT KLAERNER | President and CEO | Sell | 2,100.00 | 26.20 | 55,020.00 | 29,323.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000096/0001595585-20-000096-index.htm |
2019-11-21 | Brian M. Isern | 10% Share Holder | Sell | 117,940.00 | 41.01 | 4,836,719.40 | 2,954,214.00 | https://www.sec.gov/Archives/edgar/data/1595585/000174498119000002/0001744981-19-000002-index.htm |
2019-11-21 | SANDRA I COUFAL | Director | Sell | 117,940.00 | 41.01 | 4,836,719.40 | 2,954,214.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000265/0001595585-19-000265-index.htm |
2019-12-20 | EDWARD J HEJLEK | SVP, General Counsel & Secy. | Buy | 15,000.00 | 0.96 | 14,400.00 | 29,882.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000278/0001595585-19-000278-index.htm |
2020-02-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 258.00 | 35.58 | 9,179.64 | 2,991.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000011/0001595585-20-000011-index.htm |
2020-09-10 | Marc Cobo | SVP, Finance & CAO | Buy | 3,000.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000125/0001595585-20-000125-index.htm | ||
2019-08-13 | Geoffrey M. Parker | Chief Fin. Officer and Sr. VP | Buy | 4,531.00 | 33.60 | 152,241.60 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000170/0001595585-19-000170-index.htm |
2019-11-21 | Brian M. Isern | 10% Share Holder | Sell | 13,648.00 | 40.31 | 550,150.88 | 3,072,154.00 | https://www.sec.gov/Archives/edgar/data/1595585/000174498119000002/0001744981-19-000002-index.htm |
2019-11-21 | SANDRA I COUFAL | Director | Sell | 13,648.00 | 40.31 | 550,150.88 | 3,072,154.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000265/0001595585-19-000265-index.htm |
2019-11-20 | Brian M. Isern | 10% Share Holder | Sell | 33,576.00 | 40.19 | 1,349,419.44 | 3,085,802.00 | https://www.sec.gov/Archives/edgar/data/1595585/000174498119000002/0001744981-19-000002-index.htm |
2019-11-20 | SANDRA I COUFAL | Director | Sell | 33,576.00 | 40.19 | 1,349,419.44 | 3,085,802.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000265/0001595585-19-000265-index.htm |
2019-11-20 | Brian M. Isern | 10% Share Holder | Sell | 20,222.00 | 39.55 | 799,780.10 | 3,119,378.00 | https://www.sec.gov/Archives/edgar/data/1595585/000174498119000002/0001744981-19-000002-index.htm |
2019-11-20 | SANDRA I COUFAL | Director | Sell | 20,222.00 | 39.55 | 799,780.10 | 3,119,378.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000265/0001595585-19-000265-index.htm |
2020-06-15 | GERRIT KLAERNER | President and CEO | Sell | 1,900.00 | 25.71 | 48,849.00 | 31,423.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000096/0001595585-20-000096-index.htm |
2020-02-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 2,994.00 | 1.68 | 5,029.92 | 3,249.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000011/0001595585-20-000011-index.htm |
2020-03-02 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 2,994.00 | 1.68 | 5,029.92 | 3,249.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000037/0001595585-20-000037-index.htm |
2020-05-15 | GERRIT KLAERNER | President and CEO | Sell | 2,000.00 | 31.87 | 63,740.00 | 33,323.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000075/0001595585-20-000075-index.htm |
2019-08-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 3,500.00 | 1.68 | 5,880.00 | 3,500.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000192/0001595585-19-000192-index.htm |
2019-09-25 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 1,800.00 | 32.62 | 58,716.00 | 3,500.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000213/0001595585-19-000213-index.htm |
2020-05-15 | GERRIT KLAERNER | President and CEO | Sell | 2,000.00 | 31.24 | 62,480.00 | 35,323.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000075/0001595585-20-000075-index.htm |
2019-05-31 | KATHRYN E FALBERG | Director | Buy | 1,879.00 | 37,090.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000105/0001595585-19-000105-index.htm | ||
2020-04-15 | GERRIT KLAERNER | President and CEO | Sell | 100.00 | 27.97 | 2,797.00 | 37,323.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000053/0001595585-20-000053-index.htm |
2020-04-15 | GERRIT KLAERNER | President and CEO | Sell | 3,900.00 | 27.46 | 107,094.00 | 37,423.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000053/0001595585-20-000053-index.htm |
2020-09-10 | Robert McKague | EVP, General Counsel | Buy | 4,000.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000122/0001595585-20-000122-index.htm | ||
2020-09-10 | Susannah Cantrell | EVP, Chief Comm. Officer | Buy | 4,000.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000123/0001595585-20-000123-index.htm | ||
2019-07-03 | Claire Lockey | Chief Dev. Officer and Sr. VP | Buy | 40,000.00 | 0.80 | 32,000.00 | 40,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000124/0001595585-19-000124-index.htm |
2019-05-31 | KLAUS R DR VEITINGER | Director | Buy | 1,879.00 | 41,315.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000107/0001595585-19-000107-index.htm | ||
2019-07-03 | KLAUS R DR VEITINGER | Director | Sell | 3,100.00 | 36.91 | 114,421.00 | 41,315.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000127/0001595585-19-000127-index.htm |
2019-07-05 | KLAUS R DR VEITINGER | Director | Sell | 1,100.00 | 36.29 | 39,919.00 | 41,315.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000139/0001595585-19-000139-index.htm |
2019-07-25 | KLAUS R DR VEITINGER | Director | Sell | 1,400.00 | 31.61 | 44,254.00 | 41,315.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000143/0001595585-19-000143-index.htm |
2019-08-26 | KLAUS R DR VEITINGER | Director | Sell | 1,400.00 | 33.18 | 46,452.00 | 41,315.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000188/0001595585-19-000188-index.htm |
2019-09-26 | KLAUS R DR VEITINGER | Director | Sell | 121.00 | 32.45 | 3,926.45 | 41,315.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000218/0001595585-19-000218-index.htm |
2019-10-25 | KLAUS R DR VEITINGER | Director | Sell | 1,750.00 | 36.31 | 63,542.50 | 41,315.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000240/0001595585-19-000240-index.htm |
2019-11-01 | KLAUS R DR VEITINGER | Director | Sell | 1,750.00 | 38.88 | 68,040.00 | 41,315.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000246/0001595585-19-000246-index.htm |
2020-03-16 | GERRIT KLAERNER | President and CEO | Sell | 4,000.00 | 23.91 | 95,640.00 | 41,323.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000047/0001595585-20-000047-index.htm |
2019-09-26 | KLAUS R DR VEITINGER | Director | Sell | 585.00 | 32.05 | 18,749.25 | 41,436.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000218/0001595585-19-000218-index.htm |
2019-09-26 | KLAUS R DR VEITINGER | Director | Sell | 694.00 | 30.66 | 21,278.04 | 42,021.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000218/0001595585-19-000218-index.htm |
2019-07-05 | KLAUS R DR VEITINGER | Director | Buy | 1,100.00 | 0.80 | 880.00 | 42,415.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000139/0001595585-19-000139-index.htm |
2019-07-25 | KLAUS R DR VEITINGER | Director | Buy | 1,400.00 | 0.80 | 1,120.00 | 42,715.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000143/0001595585-19-000143-index.htm |
2019-08-26 | KLAUS R DR VEITINGER | Director | Buy | 1,400.00 | 0.80 | 1,120.00 | 42,715.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000188/0001595585-19-000188-index.htm |
2019-09-26 | KLAUS R DR VEITINGER | Director | Buy | 1,400.00 | 0.80 | 1,120.00 | 42,715.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000218/0001595585-19-000218-index.htm |
2020-06-11 | KATHRYN E FALBERG | Director | Buy | 5,670.00 | 42,760.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000085/0001595585-20-000085-index.htm | ||
2019-10-25 | KLAUS R DR VEITINGER | Director | Buy | 1,750.00 | 0.80 | 1,400.00 | 43,065.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000240/0001595585-19-000240-index.htm |
2019-11-01 | KLAUS R DR VEITINGER | Director | Buy | 1,750.00 | 0.80 | 1,400.00 | 43,065.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000246/0001595585-19-000246-index.htm |
2019-07-03 | KLAUS R DR VEITINGER | Director | Buy | 3,100.00 | 0.80 | 2,480.00 | 44,415.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000127/0001595585-19-000127-index.htm |
2019-11-01 | Claire Lockey | Chief Dev. Officer and Sr. VP | Buy | 448.00 | 0.80 | 358.40 | 448.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000244/0001595585-19-000244-index.htm |
2020-02-18 | GERRIT KLAERNER | President and CEO | Sell | 4,000.00 | 36.10 | 144,400.00 | 45,323.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000013/0001595585-20-000013-index.htm |
2020-09-10 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 4,000.00 | 4,637.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000126/0001595585-20-000126-index.htm | ||
2020-02-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 210.00 | 1.68 | 352.80 | 465.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000011/0001595585-20-000011-index.htm |
2020-03-02 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 210.00 | 1.68 | 352.80 | 465.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000037/0001595585-20-000037-index.htm |
2020-04-29 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 210.00 | 1.68 | 352.80 | 465.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000055/0001595585-20-000055-index.htm |
2020-05-08 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 210.00 | 1.68 | 352.80 | 465.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000068/0001595585-20-000068-index.htm |
2020-06-11 | KLAUS R DR VEITINGER | Director | Buy | 5,670.00 | 46,985.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000086/0001595585-20-000086-index.htm | ||
2019-10-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 4,774.00 | 2.39 | 11,409.86 | 4,774.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000242/0001595585-19-000242-index.htm |
2019-12-10 | SANDRA I COUFAL | Director | Sell | 1,620.00 | 43.17 | 69,935.40 | 4,860.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000273/0001595585-19-000273-index.htm |
2019-11-18 | Geoffrey M. Parker | Chief Fin. Officer and Sr. VP | Buy | 19,055.00 | 34.28 | 653,205.40 | 49,055.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000262/0001595585-19-000262-index.htm |
2020-01-15 | GERRIT KLAERNER | President and CEO | Sell | 4,000.00 | 35.26 | 141,040.00 | 49,323.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000008/0001595585-20-000008-index.htm |
2019-07-29 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 5,000.00 | 1.68 | 8,400.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000147/0001595585-19-000147-index.htm |
2019-11-19 | Geoffrey M. Parker | Chief Fin. Officer and Sr. VP | Buy | 945.00 | 34.72 | 32,810.40 | 50,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000262/0001595585-19-000262-index.htm |
2019-11-01 | KLAUS R DR VEITINGER | Director | Sell | 1,750.00 | 38.87 | 68,022.50 | 51,444.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000246/0001595585-19-000246-index.htm |
2019-11-01 | KLAUS R DR VEITINGER | Director | Sell | 1,750.00 | 38.88 | 68,040.00 | 51,444.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000246/0001595585-19-000246-index.htm |
2019-10-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 526.00 | 1.68 | 883.68 | 526.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000242/0001595585-19-000242-index.htm |
2019-09-25 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 5,300.00 | 1.68 | 8,904.00 | 5,300.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000213/0001595585-19-000213-index.htm |
2019-10-25 | KLAUS R DR VEITINGER | Director | Sell | 1,750.00 | 36.29 | 63,507.50 | 53,194.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000240/0001595585-19-000240-index.htm |
2019-10-25 | KLAUS R DR VEITINGER | Director | Sell | 1,750.00 | 36.30 | 63,525.00 | 53,194.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000240/0001595585-19-000240-index.htm |
2019-12-18 | GERRIT KLAERNER | President and CEO | Sell | 103.00 | 39.66 | 4,084.98 | 53,323.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000277/0001595585-19-000277-index.htm |
2019-12-18 | GERRIT KLAERNER | President and CEO | Sell | 3,987.00 | 38.93 | 155,213.91 | 53,426.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000277/0001595585-19-000277-index.htm |
2020-07-01 | GERRIT KLAERNER | President and CEO | Sell | 4,000.00 | 27.15 | 108,600.00 | 547,321.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000104/0001595585-20-000104-index.htm |
2019-09-26 | KLAUS R DR VEITINGER | Director | Sell | 153.00 | 32.42 | 4,960.26 | 54,944.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000218/0001595585-19-000218-index.htm |
2019-09-26 | KLAUS R DR VEITINGER | Director | Sell | 103.00 | 32.47 | 3,344.41 | 54,944.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000218/0001595585-19-000218-index.htm |
2020-03-10 | Geoffrey M. Parker | Chief Fin. Officer and EVP | Buy | 5,000.00 | 29.46 | 147,300.00 | 55,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000038/0001595585-20-000038-index.htm |
2019-09-26 | KLAUS R DR VEITINGER | Director | Sell | 573.00 | 32.12 | 18,404.76 | 55,047.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000218/0001595585-19-000218-index.htm |
2019-09-26 | KLAUS R DR VEITINGER | Director | Sell | 570.00 | 32.01 | 18,245.70 | 55,097.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000218/0001595585-19-000218-index.htm |
2019-05-31 | David Hirsch | Director | Buy | 1,879.00 | 5,511.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000106/0001595585-19-000106-index.htm | ||
2019-05-31 | David P Bonita | Director | Buy | 1,879.00 | 5,511.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000103/0001595585-19-000103-index.htm | ||
2020-06-01 | GERRIT KLAERNER | President and CEO | Sell | 4,000.00 | 26.23 | 104,920.00 | 551,321.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000082/0001595585-20-000082-index.htm |
2020-05-01 | GERRIT KLAERNER | President and CEO | Sell | 100.00 | 29.51 | 2,951.00 | 555,321.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000057/0001595585-20-000057-index.htm |
2020-05-01 | GERRIT KLAERNER | President and CEO | Sell | 850.00 | 28.86 | 24,531.00 | 555,421.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000057/0001595585-20-000057-index.htm |
2020-09-10 | GERRIT KLAERNER | President and CEO | Buy | 8,000.00 | 555,993.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000120/0001595585-20-000120-index.htm | ||
2019-09-26 | KLAUS R DR VEITINGER | Director | Sell | 724.00 | 30.72 | 22,241.28 | 55,620.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000218/0001595585-19-000218-index.htm |
2020-05-01 | GERRIT KLAERNER | President and CEO | Sell | 3,050.00 | 27.68 | 84,424.00 | 556,271.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000057/0001595585-20-000057-index.htm |
2019-09-26 | KLAUS R DR VEITINGER | Director | Sell | 677.00 | 30.72 | 20,797.44 | 55,667.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000218/0001595585-19-000218-index.htm |
2020-04-06 | GERRIT KLAERNER | President and CEO | Sell | 4,000.00 | 24.22 | 96,880.00 | 559,321.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000049/0001595585-20-000049-index.htm |
2019-09-03 | Geoffrey M. Parker | Chief Fin. Officer and Sr. VP | Buy | 54,347.00 | 1.84 | 99,998.48 | 56,122.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000206/0001595585-19-000206-index.htm |
2020-03-02 | GERRIT KLAERNER | President and CEO | Sell | 4,000.00 | 31.53 | 126,120.00 | 563,321.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000035/0001595585-20-000035-index.htm |
2019-08-26 | KLAUS R DR VEITINGER | Director | Sell | 1,400.00 | 33.14 | 46,396.00 | 56,344.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000188/0001595585-19-000188-index.htm |
2019-08-26 | KLAUS R DR VEITINGER | Director | Sell | 1,400.00 | 33.17 | 46,438.00 | 56,344.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000188/0001595585-19-000188-index.htm |
2020-02-03 | GERRIT KLAERNER | President and CEO | Sell | 2,900.00 | 36.58 | 106,082.00 | 567,321.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000009/0001595585-20-000009-index.htm |
2020-02-03 | GERRIT KLAERNER | President and CEO | Sell | 1,100.00 | 35.68 | 39,248.00 | 570,221.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000009/0001595585-20-000009-index.htm |
2020-01-02 | GERRIT KLAERNER | President and CEO | Sell | 100.00 | 38.00 | 3,800.00 | 571,321.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000001/0001595585-20-000001-index.htm |
2020-01-02 | GERRIT KLAERNER | President and CEO | Sell | 3,900.00 | 37.13 | 144,807.00 | 571,421.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000001/0001595585-20-000001-index.htm |
2019-12-18 | GERRIT KLAERNER | President and CEO | Sell | 18,440.00 | 38.91 | 717,500.40 | 57,413.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000277/0001595585-19-000277-index.htm |
2019-12-11 | GERRIT KLAERNER | President and CEO | Sell | 2,369.00 | 43.88 | 103,951.72 | 575,321.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000272/0001595585-19-000272-index.htm |
2019-07-25 | KLAUS R DR VEITINGER | Director | Sell | 1,400.00 | 31.62 | 44,268.00 | 57,744.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000143/0001595585-19-000143-index.htm |
2019-07-25 | KLAUS R DR VEITINGER | Director | Sell | 1,400.00 | 31.64 | 44,296.00 | 57,744.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000143/0001595585-19-000143-index.htm |
2019-12-11 | GERRIT KLAERNER | President and CEO | Sell | 5,203.00 | 43.32 | 225,393.96 | 577,690.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000272/0001595585-19-000272-index.htm |
2019-12-10 | GERRIT KLAERNER | President and CEO | Sell | 3,948.00 | 43.28 | 170,869.44 | 582,893.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000271/0001595585-19-000271-index.htm |
2019-12-02 | GERRIT KLAERNER | President and CEO | Sell | 4,000.00 | 39.49 | 157,960.00 | 586,841.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000269/0001595585-19-000269-index.htm |
2019-11-29 | GERRIT KLAERNER | President and CEO | Sell | 2,000.00 | 39.80 | 79,600.00 | 590,841.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000269/0001595585-19-000269-index.htm |
2019-07-05 | KLAUS R DR VEITINGER | Director | Sell | 1,192.00 | 36.30 | 43,269.60 | 59,144.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000139/0001595585-19-000139-index.htm |
2019-11-01 | GERRIT KLAERNER | President and CEO | Sell | 100.00 | 39.10 | 3,910.00 | 592,841.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000245/0001595585-19-000245-index.htm |
2019-11-01 | GERRIT KLAERNER | President and CEO | Sell | 14,900.00 | 38.74 | 577,226.00 | 592,941.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000245/0001595585-19-000245-index.htm |
2019-09-03 | Claire Lockey | Chief Dev. Officer and Sr. VP | Sell | 9,398.00 | 33.72 | 316,900.56 | 602.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000209/0001595585-19-000209-index.htm |
2019-07-03 | KLAUS R DR VEITINGER | Director | Sell | 3,008.00 | 36.89 | 110,965.12 | 60,336.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000127/0001595585-19-000127-index.htm |
2019-07-03 | KLAUS R DR VEITINGER | Director | Sell | 3,000.00 | 36.91 | 110,730.00 | 60,344.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000127/0001595585-19-000127-index.htm |
2019-11-01 | GERRIT KLAERNER | President and CEO | Sell | 10,854.00 | 38.75 | 420,592.50 | 607,841.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000245/0001595585-19-000245-index.htm |
2020-09-10 | Geoffrey M. Parker | Chief Fin. Officer and EVP | Buy | 4,000.00 | 60,837.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000121/0001595585-20-000121-index.htm | ||
2019-11-01 | GERRIT KLAERNER | President and CEO | Sell | 4,146.00 | 37.86 | 156,967.56 | 618,695.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000245/0001595585-19-000245-index.htm |
2019-11-01 | GERRIT KLAERNER | President and CEO | Sell | 11,108.00 | 38.74 | 430,323.92 | 622,841.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000245/0001595585-19-000245-index.htm |
2019-11-01 | GERRIT KLAERNER | President and CEO | Sell | 3,892.00 | 37.84 | 147,273.28 | 633,949.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000245/0001595585-19-000245-index.htm |
2019-11-01 | GERRIT KLAERNER | President and CEO | Sell | 1,503.00 | 38.54 | 57,925.62 | 637,841.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000245/0001595585-19-000245-index.htm |
2019-11-01 | GERRIT KLAERNER | President and CEO | Sell | 2,497.00 | 37.78 | 94,336.66 | 639,344.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000245/0001595585-19-000245-index.htm |
2019-11-01 | Claire Lockey | Chief Dev. Officer and Sr. VP | Sell | 3,700.00 | 37.72 | 139,564.00 | 6,400.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000244/0001595585-19-000244-index.htm |
2019-10-28 | GERRIT KLAERNER | President and CEO | Sell | 68.00 | 37.88 | 2,575.84 | 641,841.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000241/0001595585-19-000241-index.htm |
2019-10-28 | GERRIT KLAERNER | President and CEO | Sell | 1,932.00 | 37.23 | 71,928.36 | 641,909.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000241/0001595585-19-000241-index.htm |
2019-10-01 | GERRIT KLAERNER | President and CEO | Sell | 200.00 | 31.48 | 6,296.00 | 643,841.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000223/0001595585-19-000223-index.htm |
2019-10-01 | GERRIT KLAERNER | President and CEO | Sell | 2,919.00 | 31.19 | 91,043.61 | 644,041.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000223/0001595585-19-000223-index.htm |
2019-09-30 | GERRIT KLAERNER | President and CEO | Sell | 2,000.00 | 30.66 | 61,320.00 | 646,960.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000221/0001595585-19-000221-index.htm |
2019-11-20 | SANDRA I COUFAL | Director | Sell | 1,520.00 | 40.24 | 61,164.80 | 6,480.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000265/0001595585-19-000265-index.htm |
2019-09-30 | GERRIT KLAERNER | President and CEO | Sell | 164.00 | 31.29 | 5,131.56 | 648,960.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000221/0001595585-19-000221-index.htm |
2019-09-30 | GERRIT KLAERNER | President and CEO | Sell | 2,995.00 | 30.70 | 91,946.50 | 649,124.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000221/0001595585-19-000221-index.htm |
2019-08-28 | GERRIT KLAERNER | President and CEO | Sell | 2,000.00 | 33.71 | 67,420.00 | 652,119.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000191/0001595585-19-000191-index.htm |
2019-07-29 | GERRIT KLAERNER | President and CEO | Sell | 2,000.00 | 31.17 | 62,340.00 | 654,119.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000146/0001595585-19-000146-index.htm |
2020-02-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 2,336.00 | 36.74 | 85,824.64 | 655.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000011/0001595585-20-000011-index.htm |
2019-07-08 | GERRIT KLAERNER | President and CEO | Sell | 1,314.00 | 34.63 | 45,503.82 | 656,119.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000137/0001595585-19-000137-index.htm |
2019-07-05 | GERRIT KLAERNER | President and CEO | Sell | 1,615.00 | 36.28 | 58,592.20 | 657,433.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000137/0001595585-19-000137-index.htm |
2019-07-03 | GERRIT KLAERNER | President and CEO | Sell | 3,371.00 | 37.07 | 124,962.97 | 659,048.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000129/0001595585-19-000129-index.htm |
2020-05-05 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 452.00 | 2.39 | 1,080.28 | 707.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000064/0001595585-20-000064-index.htm |
2020-05-11 | Geoffrey M. Parker | Chief Fin. Officer and EVP | Buy | 12,404.00 | 29.48 | 365,669.92 | 72,404.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000069/0001595585-20-000069-index.htm |
2019-11-26 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 1,616.00 | 39.60 | 63,993.60 | 739.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000268/0001595585-19-000268-index.htm |
2019-12-18 | GERRIT KLAERNER | President and CEO | Sell | 9,220.00 | 38.90 | 358,658.00 | 75,853.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000277/0001595585-19-000277-index.htm |
2019-11-21 | Brian M. Isern | 10% Share Holder | Sell | 59,094.00 | 41.09 | 2,428,172.46 | 777,411.00 | https://www.sec.gov/Archives/edgar/data/1595585/000174498119000002/0001744981-19-000002-index.htm |
2019-11-21 | SANDRA I COUFAL | Director | Sell | 59,094.00 | 41.09 | 2,428,172.46 | 777,411.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000265/0001595585-19-000265-index.htm |
2020-02-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 523.00 | 2.39 | 1,249.97 | 778.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000011/0001595585-20-000011-index.htm |
2020-02-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 523.00 | 7.49 | 3,917.27 | 778.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000011/0001595585-20-000011-index.htm |
2020-03-02 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 523.00 | 2.39 | 1,249.97 | 778.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000037/0001595585-20-000037-index.htm |
2020-03-02 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 523.00 | 7.49 | 3,917.27 | 778.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000037/0001595585-20-000037-index.htm |
2020-04-29 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 523.00 | 2.39 | 1,249.97 | 778.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000055/0001595585-20-000055-index.htm |
2020-04-29 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 523.00 | 7.49 | 3,917.27 | 778.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000055/0001595585-20-000055-index.htm |
2020-05-08 | Dawn Parsell Otto | EVP, Clinical Development | Buy | 523.00 | 7.49 | 3,917.27 | 778.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000068/0001595585-20-000068-index.htm |
2019-10-28 | Dawn Parsell Otto | Sr VP, Clinical Development | Sell | 448.00 | 37.11 | 16,625.28 | 78.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000242/0001595585-19-000242-index.htm |
2019-11-07 | SANDRA I COUFAL | Director | Sell | 100.00 | 40.02 | 4,002.00 | 8,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000251/0001595585-19-000251-index.htm |
2019-11-01 | SANDRA I COUFAL | Director | Sell | 1,625.00 | 38.75 | 62,968.75 | 8,100.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000243/0001595585-19-000243-index.htm |
2019-11-20 | Brian M. Isern | 10% Share Holder | Sell | 37,614.00 | 40.27 | 1,514,715.78 | 836,505.00 | https://www.sec.gov/Archives/edgar/data/1595585/000174498119000002/0001744981-19-000002-index.htm |
2019-11-20 | SANDRA I COUFAL | Director | Sell | 37,614.00 | 40.27 | 1,514,715.78 | 836,505.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000265/0001595585-19-000265-index.htm |
2019-11-29 | GERRIT KLAERNER | President and CEO | Sell | 2,000.00 | 39.80 | 79,600.00 | 85,073.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000269/0001595585-19-000269-index.htm |
2019-10-28 | GERRIT KLAERNER | President and CEO | Sell | 727.00 | 37.59 | 27,327.93 | 87,073.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000241/0001595585-19-000241-index.htm |
2019-11-20 | Brian M. Isern | 10% Share Holder | Sell | 19,173.00 | 39.54 | 758,100.42 | 874,119.00 | https://www.sec.gov/Archives/edgar/data/1595585/000174498119000002/0001744981-19-000002-index.htm |
2019-11-20 | SANDRA I COUFAL | Director | Sell | 19,173.00 | 39.54 | 758,100.42 | 874,119.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000265/0001595585-19-000265-index.htm |
2019-10-28 | GERRIT KLAERNER | President and CEO | Sell | 1,273.00 | 37.08 | 47,202.84 | 87,800.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000241/0001595585-19-000241-index.htm |
2019-10-01 | GERRIT KLAERNER | President and CEO | Sell | 1,419.00 | 31.40 | 44,556.60 | 89,073.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000223/0001595585-19-000223-index.htm |
2019-10-01 | GERRIT KLAERNER | President and CEO | Sell | 6,685.00 | 30.93 | 206,767.05 | 90,492.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000223/0001595585-19-000223-index.htm |
2019-07-03 | Dawn Parsell Otto | Sr VP, Clinical Development | Buy | 6,281.00 | 1.68 | 10,552.08 | 9,050.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000125/0001595585-19-000125-index.htm |
2020-05-11 | Geoffrey M. Parker | Chief Fin. Officer and EVP | Buy | 19,854.00 | 30.36 | 602,767.44 | 92,258.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000069/0001595585-20-000069-index.htm |
2020-05-12 | Geoffrey M. Parker | Chief Fin. Officer and EVP | Buy | 1,303.00 | 30.09 | 39,207.27 | 93,561.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000069/0001595585-20-000069-index.htm |
2020-05-12 | Geoffrey M. Parker | Chief Fin. Officer and EVP | Buy | 1,439.00 | 31.66 | 45,558.74 | 95,000.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558520000069/0001595585-20-000069-index.htm |
2019-12-11 | David P Bonita | Director | Sell | 1,500,000.00 | 40.00 | 60,000,000.00 | 9,614,280.00 | https://www.sec.gov/Archives/edgar/data/1595585/000094787119000960/0000947871-19-000960-index.htm |
2019-12-11 | ORBIMED ADVISORS LLC | Director | Sell | 1,500,000.00 | 40.00 | 60,000,000.00 | 9,614,280.00 | https://www.sec.gov/Archives/edgar/data/1595585/000094787119000959/0000947871-19-000959-index.htm |
2019-09-30 | GERRIT KLAERNER | President and CEO | Sell | 58.00 | 31.06 | 1,801.48 | 97,177.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000221/0001595585-19-000221-index.htm |
2019-09-30 | GERRIT KLAERNER | President and CEO | Sell | 1,942.00 | 30.64 | 59,502.88 | 97,235.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000221/0001595585-19-000221-index.htm |
2019-07-08 | SANDRA I COUFAL | Director | Sell | 380.00 | 34.63 | 13,159.40 | 9,725.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000136/0001595585-19-000136-index.htm |
2019-09-30 | GERRIT KLAERNER | President and CEO | Sell | 100.00 | 31.14 | 3,114.00 | 99,177.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000221/0001595585-19-000221-index.htm |
2019-09-30 | GERRIT KLAERNER | President and CEO | Sell | 2,996.00 | 30.68 | 91,917.28 | 99,277.00 | https://www.sec.gov/Archives/edgar/data/1595585/000159558519000221/0001595585-19-000221-index.htm |